title: Putting a lid on chemotherapy costs.
abstract: Genomic Health's Oncotype DX Colon Cancer Assay assesses the risk of stage II colon cancer recurrence and potential adjuvant chemotherapy benefit. Cost savings could be huge.
authors.forename: Bob
authors.initials: B
authors.lastname: Carlson